NeurotechMagProGet access
Clinical Trial

The Clinical Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus (STN-DBS) Versus Bilateral Deep Brain Stimulation of the Caudal Zona Incerta (cZI-DBS) in Patients With Idiopathic Parkinson's Disease

ClinicalTrials.gov4/24/2009ยท04/24/09๐ŸŒ Europe

Summary

The aim of this study is to analyze the effects of two different targets of deep brain stimulation: caudal Zona incerta and Nucleus subthalamicus. The present study will investigate the effects of DBS using a blind, randomized and stratified design in patients with Parkinson's disease. The study involves the use of deep brain stimulation and will assess clinical outcomes in participants with Parkinson's Disease.

Why it matters

This research addresses an important unmet clinical need in treating Parkinson's Disease through innovative neurotechnology approaches. The findings from this study could meaningfully advance patient care by providing rigorous clinical evidence for new therapeutic interventions. Successful results may ultimately lead to improved treatment guidelines, expanded access to care, and significantly better long-term outcomes for affected patients worldwide.

#Phase 1#Deep Brain Stimulation#Parkinson's#Neurostimulation

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items โ€” updated daily.

Start free trial
Already a member? Sign in